Nanit Raises $50M to Push Baby Monitor Into Milestone Tracking

Nanit, the smart baby-camera company, spent the tail end of last year raising fresh capital to move its product beyond video streaming and into something more ambitious: continuously modeling infant development. According to the New York Times, Nanit and rival Owlet are pushing camera- and sensor-based monitors toward what marketers are calling parenting intelligence.

The concrete new fact is the money. In December 2025 Nanit closed a $50 million growth round led by Springcoast Partners, with Upfront Ventures and JVP participating, bringing total funding to $125.1 million, as reported by Forbes. The company says the capital is going into a Parenting Intelligence System launching in 2026 that would go well beyond sleep tracking to log movement signatures, breathing patterns, motor-skill milestones, and speech and language patterns, plus trends the company claims may predict metabolic, emotional, or cognitive challenges.

Nanit's pitch has always leaned on the overhead camera and computer vision, with no wearable on the baby, while Owlet's Dream Sock uses FDA-cleared pulse oximetry to read SpO2 and heart rate. That divide is why the two are the natural pairing in any story about the category: one is a camera company teaching itself to read a nursery, the other a medical-adjacent wearable maker. Nanit itself is now positioning less as a camera brand and more as a subscription platform, competing at the premium end alongside Owlet, Cubo AI, and Miku.

The honest caveat is that language about predicting cognitive or metabolic challenges is a marketing claim from a company promoting its next product, not a peer-reviewed clinical result. Continuous developmental profiling of infants drags every question smart-home devices already had, around retention, sharing, and breach exposure, into a much more sensitive dataset. What the reporting doesn't spell out is where those inferences would sit for regulators, whether pediatricians will trust them, or which alerts a subscription-tier product ends up gating behind a paywall.

The upside worth watching is not the hardware race. It is whether a company sitting on years of longitudinal infant video and audio can turn that into something clinicians and researchers actually use, rather than a nicer chart in a parent's app.